Republicans have just weeks left of control of Congress. Here's what to expect. And, Trump has appointed Stephen Miller as his new chief of staff, signaling his readiness to confront his opposition.
S&P 500 Index futures are up 0.7% at 7:39 a.m. in New York as dip-buyers picked up beaten-down shares following the S&P 500’s worst week since April 2025.
Nvidia’s CEO admitted to having an affair with a suspected Chinese spy. The reaction of prominent U.S. officials provides a window into what may happen next.
Our NFL experts pitched trade offers they'd love to see get done before Tuesday's deadline, including moves for Tony Pollard, Riq Woolen, Jonathan Taylor and Jessie Bates III.
Formation Securities plans to launch in early 2027 with Galaxy, Exodus and Forward Industries shares, expanding the U.S. regulator's experiment in blockchain-based stock trading.
Chelsea warn staff to be careful about revealing team news through Fantasy Premier League after Joao Pedro's injury appeared to have been inadvertently disclosed through team selections.
Superior Group (SGC) delivered earnings and revenue surprises of -5.56% and +1.72%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Montes Archimedes Acquisition (ROIV) delivered earnings and revenue surprises of +53.66% and +1,252.37%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Foghorn Therapeutics (FHTX) delivered earnings and revenue surprises of +447.83% and +974.37%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
GCM Grosvenor (GCMG) delivered earnings and revenue surprises of +4.76% and -5.49%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Ocular Therapeutix (OCUL) delivered earnings and revenue surprises of -16.67% and -7.45%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
ADC Therapeutics (ADCT) delivered earnings and revenue surprises of +23.81% and +5.67%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
President Donald Trump meets with Qatar's prime minister at the White House as Washington seeks an agreement to end the U.S.-Iran war amid warnings from Tehran.
Michael Allen discusses Marco Rubio arriving in Paris for high-stakes G7 foreign ministers meetings following another weekend of intense riots and street clashes in France.